A composite (N-rGO@ppy) of N-doped reduced graphene oxide (N-rGO) coated with polypyrrole (ppy) particles was successfully synthesized. The incorporation of N-rGO significantly mitigates the aggregation of ppy synthesized in situ, and the doped N atoms improve the conductivity of graphene oxide (GO), thereby enhancing N-rGO@ppy’s redox properties. Firstly, a glassy carbon electrode (GCE) modified with N-rGO@ppy (N-rGO@ppy/GCE) was used in combination with a bismuth film and square-wave anodic stripping voltammetry (SWASV) for the simultaneous trace analysis of Pb²⁺ and Cd²⁺. N-rGO@ppy/GCE exhibited distinct stripping peaks for Pb²⁺ and Cd²⁺, with a linear range of 1 to 500 μg L⁻¹. The limits of detection (LODs) were found to be 0.080 μg L⁻¹ for Pb²⁺ and 0.029 μg L⁻¹ for Cd²⁺, both of which are significantly below the standards set by the World Health Organization (WHO). Subsequently, the same electrochemical sensing strategy was adapted to a more portable screen-printed electrode (SPE) to accommodate the demand for in situ detection. The performance of N-rGO@ppy/SPE for analyzing Pb²⁺ and Cd²⁺ in actual samples, such as drinking water, milk, and honey, showed results consistent with those obtained from conventional graphite furnace atomic absorption spectrometry (GFAAS).

Calcins represent a class of novel peptide ligands for ryanodine receptors (RyRs), demonstrating therapeutic potential against Ca²⁺ dysregulation-related cardiac diseases. Nevertheless, their biological effects beyond RyR modulation and underlying mechanisms remain unexplored. This study employed Opicalcin1 (OpiCa1), the most bioactive calcin member, revealing that while it reduced cytosolic Ca²⁺ in H9c2 cardiomyocytes, it concurrently diminished cell viability and promoted apoptosis. Transcriptomics and Western blot analyses identified suppression of the negatively regulatory PI3K/Akt pathway as the mechanistic basis. In acute/chronic in vivo studies, high-dose OpiCa1 (≥50 mg/kg i.v.) exhibited minimal impact on body weight, histopathology, and organ indices, while accompanied with subtle alterations in serum indicators, including slight elevations in AST, ALT, and LDH, alongside mild reductions in CK-MB and TBIL-Z. These findings unveil OpiCa1’s modulation on cardiomyocyte viability through PI3K/Akt inhibition with minimal systemic impact, providing new insights into non-RyR-mediated actions of calcins and critical toxicological support for developing calcin-based therapies targeting Ca²⁺-dysregulated cardiac pathologies.

Accurate detection of residual jellyfish venom is crucial for species identification and clinical management post-envenomation. We developed a highly specific immunoassay for Nemopilema nomurai venom using polyclonal antibodies (titer: 1:256,000). The established i-ELISA exhibited linear detection (0–20 ng/mL) with low variability (intra-plate CV: 0.77–2.78%; inter-plate CV: 2.25–5.17%). The kit demonstrated remarkable thermal stability (1-year shelf life at 4 °C. It showed significantly higher sensitivity for N. nomurai venom than venoms from Rhopilema esculentum, Chrysaora quinquecirrha, Cyanea melanaster, scorpions, or bees (p < 0.01). Validation in murine/human skin envenomation models and serum from systemically intoxicated mice confirmed the reproducibility and stability of residual toxins. This study developed a highly sensitive, specific, reproducible, and stable i-ELISA for Nemopilema nomurai venom, providing a methodological basis for creating diagnostic kits for marine envenomation.